Breaking News Instant updates and real-time market news.

CATB

Catabasis Pharmaceuticals

$5.40

-0.39 (-6.74%)

08:01
10/05/16
10/05
08:01
10/05/16
08:01

Catabasis Pharmaceuticals promotes Andrew Nicholas to Chief Scientific Officer

Catabasis Pharmaceuticals announced the promotion of Andrew Nichols, Ph.D. to Chief Scientific Officer and Angelika Fretzen, Ph.D., to Senior Vice President of Product Development. Dr. Nichols has more than 25 years of drug development experience, leading efforts from target discovery through translational research and early clinical development for pharmaceutical and biotechnology companies. Dr. Fretzen has 15 plus years of entrepreneurial drug discovery and development experience.

CATB Catabasis Pharmaceuticals
$5.40

-0.39 (-6.74%)

12/10/15
WEDB
12/10/15
NO CHANGE
Target $27
WEDB
Outperform
Catabasis results could lead to partnership discussions, says Wedbush
Wedbush analyst Liana Moussatos said Catabsis announced the initiation of its Phase 2a trial of CAT-2054, its orally available SREBP inhibitor, in patients with hypercholesterolemia. Moussatos believes results from this trial could provide a basis for partnering discussions with a Big Pharma company with a presence in the metabolic space. The analyst sees potential peak worldwide sales of over $5.7B, and a partnering deal could have a lucrative upfront payment as well as significant milestones and royalties. Moussatos rates Catabasis an Outperform with a $27 price target on shares.
04/08/16
SBSH
04/08/16
NO CHANGE
SBSH
Citi lays out potential targets after break of Pfizer, Allergan deal
Citi analysts Yigal Nochomovitz, Liav Abraham and Joel Beatty argue that the break of the Pfizer (PFE), Allergan (AGN) merger could accelerate smaller scale acquisitions in the Biotechnology sector. The implication that larger companies could accelerate M&A activity to bolster pipelines in lieu of the mega-merger pathway aided shares in the sector this week, the analysts contend in a research note. They now believe that Ardelyx (ARDX), Medivation (MDVN), Ophthotech (OPHT), Puma Biotechnology (PBYI), Portola Pharmaceuticals (PTLA), Ultragenyx (RARE), Relypsa (RLYP) and Versartis (VSAR) have a greater probability of being acquired in the next 12-18 months. Beside these favored names for a takeover, analyst Joel Beatty sees a greater chance of Catabasis Pharmaceuticals (CATB), Intercept Pharmaceuticals (ICPT), Novavax (NVAX) and Raptor Pharmaceuticals (RPTP) getting acquired over the next 18 months.
06/08/16
COWN
06/08/16
NO CHANGE
Target $30
COWN
Outperform
Catabasis Pharmaceuticals DMD drug potential undervalued, says Cowen
Cowen noted Catabasis Pharmaceuticals halted its Phase-2 trial for CAT-2054 as it did not meet its primary endpoint in reducing LDL in hypercholesterolemia. Cowen, however, feels the shares are undervalued based on the potential of its edasalonexent drug candidate for Duchenne muscular dystropy, or DMD. The firm said the drug has the potential to be effective in all DMD patients regardless of the patient's underlying dystrophin mutation. Cowen maintained its Outperform rating and $30 price target on Catabasis shares.
06/09/16
SBSH
06/09/16
NO CHANGE
Target $8
SBSH
Buy
Catabasis Pharmaceuticals price target lowered to $8 from $16 at Citi
Citi analyst Joel Beatty halved his price target for Catabasis Pharmaceuticals to $8 and removed CAT-2054 from his model after the agent failed to lower cholesterol on top of statins in a Phase 2 trial. The analyst, however, continues to see favorable risk/reward into Phase 2 data in late 2016 for lead agent CAT-1004 in Duchenne Muscular Dystrophy. Beatty keeps a Buy rating on Catabasis.

TODAY'S FREE FLY STORIES

12:40
06/22/17
06/22
12:40
06/22/17
12:40
General news
Fed's Bullard: balance sheet unwind should start "sooner rather than later," »

Fed's Bullard:…

GE

General Electric

$27.70

-0.08 (-0.29%)

12:36
06/22/17
06/22
12:36
06/22/17
12:36
Periodicals
Nelson Peltz's Trian optimistic about GE, Flannery, CNBC reports »

Nelson Peltz's Trian…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 02

    Oct

FB

Facebook

$153.91

1.66 (1.09%)

, SNAP

Snap

$17.73

0.46 (2.66%)

12:33
06/22/17
06/22
12:33
06/22/17
12:33
Periodicals
Instagram job listing signals pursuit of Hollywood ties, CNBC says »

Facebook's (FB)…

FB

Facebook

$153.91

1.66 (1.09%)

SNAP

Snap

$17.73

0.46 (2.66%)

GOOG

Alphabet

$959.45

8.82 (0.93%)

GOOGL

Alphabet Class A

$978.59

9.6 (0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 19

    Jul

HCA

HCA Holdings

$87.21

3.16 (3.76%)

, LPNT

LifePoint

$64.85

0.25 (0.39%)

12:31
06/22/17
06/22
12:31
06/22/17
12:31
Hot Stocks
Hospitals, insurers rise after Republicans release draft of ACA replacement bill »

Shares of hospital and…

HCA

HCA Holdings

$87.21

3.16 (3.76%)

LPNT

LifePoint

$64.85

0.25 (0.39%)

THC

Tenet

$19.14

1.455 (8.23%)

CYH

Community Health

$9.60

0.775 (8.79%)

QHC

Quorum Health

$4.43

0.335 (8.19%)

AET

Aetna

$154.14

2.04 (1.34%)

ANTM

Anthem

$194.21

2.14 (1.11%)

CNC

Centene

$82.57

2.45 (3.06%)

CI

Cigna

$172.08

1.895 (1.11%)

HUM

Humana

$240.25

4.04 (1.71%)

MOH

Molina Healthcare

$71.57

1.84 (2.64%)

UNH

UnitedHealth

$187.73

2.81 (1.52%)

WCG

WellCare

$183.58

6.04 (3.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

TECK

Teck Resources

$16.13

0.825 (5.39%)

12:30
06/22/17
06/22
12:30
06/22/17
12:30
Options
Defensive option play in Teck Resources as shares rally »

Defensive option play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$153.91

1.66 (1.09%)

12:22
06/22/17
06/22
12:22
06/22/17
12:22
Hot Stocks
Facebook holds communities event, announces new mission »

Facebook hosted its first…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 19

    Jul

FLR

Fluor

$44.29

0.52 (1.19%)

12:20
06/22/17
06/22
12:20
06/22/17
12:20
Options
Flour calls seeing opening interest »

Flour calls seeing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

12:17
06/22/17
06/22
12:17
06/22/17
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
06/22/17
06/22
12:16
06/22/17
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSIQ

Canadian Solar

$13.99

0.94 (7.20%)

12:10
06/22/17
06/22
12:10
06/22/17
12:10
Options
Notable call buying in Canadian Solar as shares shine »

Notable call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:10
06/22/17
06/22
12:10
06/22/17
12:10
General news
Treasury Option Action: a call 1x2 on 10s »

Treasury Option Action: a…

SRSC

Sears Canada

$0.47

-0.115 (-19.69%)

12:05
06/22/17
06/22
12:05
06/22/17
12:05
Hot Stocks
Breaking Hot Stocks news story on Sears Canada »

Sears Canada trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NLSN

Nielsen

$37.08

-0.15 (-0.40%)

, GOOG

Alphabet

$959.45

8.82 (0.93%)

12:01
06/22/17
06/22
12:01
06/22/17
12:01
Hot Stocks
Nielsen launches mobile measurement for YouTube ads »

Nielsen (NLSN) announced…

NLSN

Nielsen

$37.08

-0.15 (-0.40%)

GOOG

Alphabet

$959.45

8.82 (0.93%)

GOOGL

Alphabet Class A

$978.59

9.6 (0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 19

    Jul

AKS

AK Steel

$6.25

0.055 (0.89%)

12:00
06/22/17
06/22
12:00
06/22/17
12:00
Options
AK Steel Jul 8 calls are today's most active option »

AK Steel Jul 8 calls are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

CVM

CEL-SCI

$1.75

0.0576 (3.41%)

11:58
06/22/17
06/22
11:58
06/22/17
11:58
Hot Stocks
Breaking Hot Stocks news story on CEL-SCI 

Cel Sci trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAIN

Hain Celestial

$33.16

0.13 (0.39%)

11:55
06/22/17
06/22
11:55
06/22/17
11:55
Hot Stocks
Hain Celestial CEO says he has a strong management team backing him »

The Hain Celestial CEO is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 27

    Jun

HAIN

Hain Celestial

$33.16

0.13 (0.39%)

, AMZN

Amazon.com

$1,002.23

9.64 (0.97%)

11:53
06/22/17
06/22
11:53
06/22/17
11:53
Hot Stocks
Hain Celestial says Amazon deal for Whole Foods will give more exposure »

The Hain Celestial CEO is…

HAIN

Hain Celestial

$33.16

0.13 (0.39%)

AMZN

Amazon.com

$1,002.23

9.64 (0.97%)

WFM

Whole Foods

$43.26

0.48 (1.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 27

    Jun

  • 28

    Jun

SPLS

Staples

$8.66

-0.09 (-1.03%)

11:47
06/22/17
06/22
11:47
06/22/17
11:47
Recommendations
Staples analyst commentary  »

Staples intrinsic value…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MMSI

Merit Medical

$36.80

-0.2 (-0.54%)

11:46
06/22/17
06/22
11:46
06/22/17
11:46
Recommendations
Merit Medical analyst commentary  »

Merit Medical allowance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

FSLR

First Solar

$37.23

1.78 (5.02%)

11:45
06/22/17
06/22
11:45
06/22/17
11:45
Options
First Solar call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

ABBV

AbbVie

$72.80

1.455 (2.04%)

11:44
06/22/17
06/22
11:44
06/22/17
11:44
Upgrade
AbbVie rating change  »

AbbVie upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMC

Commercial Metals

$18.47

0.06 (0.33%)

11:38
06/22/17
06/22
11:38
06/22/17
11:38
Hot Stocks
Breaking Hot Stocks news story on Commercial Metals »

Commercial Metals says a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

LPNT

LifePoint

$64.85

0.25 (0.39%)

, CYH

Community Health

$9.56

0.74 (8.39%)

11:35
06/22/17
06/22
11:35
06/22/17
11:35
Hot Stocks
Hosptial stocks at highs after Republicans release ACHA 'discussion draft' »

Publicly traded companies…

LPNT

LifePoint

$64.85

0.25 (0.39%)

CYH

Community Health

$9.56

0.74 (8.39%)

THC

Tenet

$18.94

1.26 (7.13%)

HCA

HCA Holdings

$87.44

3.39 (4.03%)

UHS

Universal Health

$116.28

3.06 (2.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYL

Mylan

$38.27

0.85 (2.27%)

11:26
06/22/17
06/22
11:26
06/22/17
11:26
Periodicals
Mylan investors vote against executive pay, re-elect board members, Reuters says »

Mylan shareholders voted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 13

    Jul

  • 03

    Sep

  • 09

    Oct

11:25
06/22/17
06/22
11:25
06/22/17
11:25
General news
Treasury announced an $88 B package of coupon offerings for next week »

Treasury announced an $88…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.